The design, synthesis and evaluation of hypoxia-activated pro-oligonucleotides

被引：23
|
作者：
Zhang, Nan [1 ,2 ]
Tan, Chunyan [1 ]
Cai, Puqin [1 ]
Zhang, Peizhuo [3 ]
Zhao, Yufen [2 ]
Jiang, Yuyang [1 ,4 ]
机构：
[1] Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518055, Guangdong, Peoples R China
[2] Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China
[3] Shanghai GenePharma Co Ltd, Shanghai 201203, Peoples R China
[4] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China
来源：
CHEMICAL COMMUNICATIONS | 2009年 / 22期
关键词：
PRODRUGS;
D O I：
10.1039/b903331a
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Hypoxia-activated pro-oligonucleotides were synthesized through the commercial phosphoramidite method, and could be readily cleaved to form normal oligos with good hypoxia selectivity in vitro under the effect of reductases, as well as in tumor cell extract.
引用
收藏
页码：3216 / 3218
页数：3
相关论文
共 50 条
  • [41] Cyclophosphamides as hypoxia-activated diffusible cytotoxins: A theoretical study
    Jian Hui Wu
    Christopher A. Reynolds
    Journal of Computer-Aided Molecular Design, 2000, 14 : 307 - 316
  • [42] Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosis
    Gautier-Veyret, Elodie
    Arnaud, Claire
    Back, Magnus
    Pepin, Jean-Louis
    Petri, Marcelo H.
    Baguet, Jean-Philippe
    Tamisier, Renaud
    Levy, Patrick
    Stanke-Labesque, Francoise
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (02) : 404 - 413
  • [43] Hypoxia-activated prodrugs in cancer therapy: progress to the clinic
    Denny, William A.
    FUTURE ONCOLOGY, 2010, 6 (03) : 419 - 428
  • [44] Hypoxia-activated prodrugs and redox-responsive nanocarriers
    Zeng, Yun
    Ma, Jingwen
    Zhan, Yonghua
    Xu, Xinyi
    Zeng, Qi
    Liang, Jimin
    Chen, Xueli
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 13 : 6551 - 6574
  • [45] Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy
    Baran, Natalia
    Konopleva, Marina
    CLINICAL CANCER RESEARCH, 2017, 23 (10) : 2382 - 2390
  • [46] Cyclophosphamides as hypoxia-activated diffusible cytotoxins: A theoretical study
    Wu, JH
    Reynolds, CA
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2000, 14 (04) : 307 - 316
  • [47] Hypoxia-activated prodrugs in the treatment of advanced pancreatic adenocarcinoma
    Babiker, Hani M.
    Riaz, Irbaz B.
    Shah, Syed R.
    Von Hoff, Daniel D.
    Borad, Mitesh J.
    ANTI-CANCER DRUGS, 2017, 28 (02) : 127 - 132
  • [48] A hypoxia-activated protein switch as a potential anticancer therapeutic
    Wright, Chapman M.
    Ostermeier, Marc
    Eshleman, James R.
    CANCER RESEARCH, 2011, 71
  • [49] The hypoxia-activated pro-drug tirapazamine suppresses outgrowth of colorectal liver metastases following radiofrequency ablation
    Govaert, Klaas M.
    Nijkamp, Maarten W.
    Emmink, Benjamin L.
    Steller, Ernst J. A.
    Minchinton, Andrew I.
    Kranenburg, Onno
    Rinkes, Inne H. M. Bore
    CANCER RESEARCH, 2012, 72
  • [50] The Hypoxia-Activated Prodrug TH-302: Exploiting Hypoxia in Cancer Therapy
    Li, Yue
    Zhao, Long
    Li, Xiao-Feng
    FRONTIERS IN PHARMACOLOGY, 2021, 12
12345